Steroids and/or cytotoxic agents should be used early in the management of patients with IPF--the pro argument.
Sharma
Sat
S
Section of Respirology, University of Manitoba, Winnipeg. ssharma@mb.sympatico.ca
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D006801:Humans; D017563:Lung Diseases, Interstitial / Q000150:complications* / Q000188:drug therapy; D011379:Prognosis; D011658:Pulmonary Fibrosis / Q000188:drug therapy* / Q000209:etiology*
D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D000964:Antimetabolites, Antineoplastic; D000970:Antineoplastic Agents; D018906:Antineoplastic Agents, Alkylating; D003520:Cyclophosphamide; D001379:Azathioprine